1 week Ago By Defense World Staff
Norges Bank bought a new stake in Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 57,617 shares of the company’s stock, valued at approximately $10,681,000.
Norges Bank owned about 0.19% of Inspire Medical Systems at the end of the most recent quarter. A number of other institutional investors also recently modified their holdings of INSP.
Smartleaf Asset Management LLC lifted its position in Inspire Medical Systems by 178.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 357 shares of the company’s stock worth $66,000 after buying an additional 229 shares in the last quarter.
Merit Financial Group LLC acquired a new position in shares of Inspire Medical Systems during the fourth quarter worth approximately $313,000. Public Employees Retirement System of Ohio grew its stake in shares of Inspire Medical Systems by 9.4% during the third quarter.
Public Employees Retirement System of Ohio now owns 36,361 shares of the company’s stock valued at $7,674,000 after purchasing an additional 3,125 shares during the last quarter. Jennison Associates LLC acquired a new stake in shares of Inspire Medical Systems in the fourth quarter valued at approximately $8,821,000. Finally, Janney Montgomery Scott LLC raised its position in Inspire Medical Systems by 248.
5% in the 4th quarter. Janney Montgomery Scott LLC now owns 4,806 shares of the company’s stock worth $891,000 after purchasing an additional 3,427 shares during the last quarter. Institutional investors own 94.
91% of the company’s stock. Inspire Medical Systems Stock PerformanceShares of INSP opened at $141.63 on Wednesday.
The firm has a market cap of $4.21 billion, a P/E ratio of 81.86, a PEG ratio of 2.
86 and a beta of 1.39. Inspire Medical Systems, Inc.
has a twelve month low of $123.00 and a twelve month high of $257.40.
The firm’s 50 day moving average price is $173.26 and its two-hundred day moving average price is $186.81.
Inspire Medical Systems (NYSE:INSP – Get Free Report) last issued its quarterly earnings results on Monday, February 10th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $0.
74 by $0.41. Inspire Medical Systems had a return on equity of 8.
19% and a net margin of 6.67%. On average, sell-side analysts anticipate that Inspire Medical Systems, Inc.
will post 2.16 earnings per share for the current fiscal year. Wall Street Analyst Weigh InINSP has been the subject of several research reports.
Truist Financial lowered their target price on Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating for the company in a research note on Tuesday, February 11th.
Wells Fargo & Company dropped their price objective on Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a report on Tuesday, February 11th.
Royal Bank of Canada restated an “outperform” rating and set a $260.00 target price on shares of Inspire Medical Systems in a research report on Tuesday, February 11th. Piper Sandler lowered their price target on shares of Inspire Medical Systems from $260.
00 to $233.00 and set an “overweight” rating for the company in a research report on Monday, February 10th. Finally, KeyCorp restated an “overweight” rating and issued a $234.
00 price objective (down from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock.
According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $226.70.Get Our Latest Stock Report on Inspire Medical SystemsInsider Transactions at Inspire Medical SystemsIn related news, CTO John Rondoni sold 583 shares of the business’s stock in a transaction on Tuesday, February 11th.
The shares were sold at an average price of $170.49, for a total transaction of $99,395.67.
Following the transaction, the chief technology officer now directly owns 10,424 shares in the company, valued at approximately $1,777,187.76. The trade was a 5.
30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Randy Ban sold 25,584 shares of the stock in a transaction on Thursday, February 13th.
The shares were sold at an average price of $183.50, for a total transaction of $4,694,664.00.
Following the completion of the sale, the insider now owns 7,259 shares of the company’s stock, valued at approximately $1,332,026.50. This represents a 77.
90 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.
30% of the company’s stock. Inspire Medical Systems Profile (Free Report)Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Further ReadingFive stocks we like better than Inspire Medical SystemsBreakout Stocks: What They Are and How to Identify ThemTariff-Proof Stocks: 3 Big Bargains With Huge Upside PotentialStock Dividend Cuts Happen Are You Ready?Qualcomm Breaks Down But RSI Signals It’s Severely OversoldHow to Start Investing in Real EstateTesla’s #1 Bull Cuts Target But Says It’s Still a BuyWant to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP – Free Report).
.
